VICTORIA ANDERSON: Open Payments
NPI 1407006083 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 36 payments from 9 companies in 2025. Trend: 2023 $345 · 2024 $926 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $331 |
| E.R. Squibb & Sons, L.L.C. | 13 | $309 |
| Teva Pharmaceuticals USA, Inc. | 5 | $168 |
| Janssen Pharmaceuticals, Inc | 3 | $149 |
| Vanda Pharmaceuticals Inc. | 3 | $142 |
| Alkermes, Inc. | 1 | $130 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Shionogi Inc | 1 | $23 |
| Lundbeck LLC | 1 | $14 |
Products named: INGREZZA, COBENFY, INVEGA SUSTENNA, FANAPT, UZEDY, ARISTADA, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
